Editorial: Bivalirudin with post-procedural infusion: Should the Guidelines change to keep up with the data?

Cardiovasc Revasc Med. 2023 Dec:57:80-81. doi: 10.1016/j.carrev.2023.08.002. Epub 2023 Aug 10.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antithrombins* / adverse effects
  • Hirudins* / adverse effects
  • Humans
  • Peptide Fragments / adverse effects

Substances

  • bivalirudin
  • Hirudins
  • Antithrombins
  • Peptide Fragments